Orthofix International | OFIX - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Accuray USD 41.89M 7.42M 2024-12
AngioDynamics USD 44.78M 2.93M 2025-09
Artivion USD 73.14M 1.25M 2025-12
AtriCure USD 109.31M 3.97M 2026-03
Dexcom USD 750.3M 42.4M 2026-03
EDAP TMS EUR 5.97M 850K 2025-09
Globus Medical USD 496.26M 39.69M 2026-03
Inogen USD 41.34M 1.39M 2024-09
Insulet USD 540.8M 27.8M 2026-03
Integra LifeSciences USD 213.21M 3.89M 2026-03
J&J USD 17.24B 642M 2026-03
Medtronic USD 6.01B 595M 2026-03
Mesa Laboratories USD 39.75M 4.3M 2024-12
Orthofix International USD 153.28M 4.76M 2025-12
Plus Therapeutics 1.37M 30K 2025-12
Smith & Nephew USD 2.09B 117M 2025-12
STAAR Surgical USD 43.74M 34.13M 2025-12
Stryker USD 3.81B 675M 2026-03
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.43M 21K 2026-03
Veracyte USD 101.16M 814K 2026-03
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12